OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals
Uppsala, Sweden, April 29 – OssDsign AB (publ.) today announces that the company has been awarded a new Veteran Affairs (VA) contract which covers approximately 100 additional VA orthopedic hospitals nationwide, giving OssDsign increased access to the important U.S. military market.
The new contract is a continuation of OssDsign’s collaboration with Red One Medical, one of the most respected medical technology private sector representatives to the U.S. government that identifies medical innovations for the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD). The Distribution and Pricing Agreement (DAPA) that the company entered into in 2021 has gradually been expanded and, with the contract covering all VA orthopedic hospitals nationwide, that means all current and retired military personnel now have access to OssDsign Catalyst.
“From the very beginning of our entry into orthobiologics, we have been highly focused on building access to hospitals throughout the U.S, including active military and veteran hospitals, and we are honored to have the opportunity to provide treatment solutions for an even larger part of America’s veterans and military staff. This new contract signifies another important step in improving our access to the U.S. market as well as a deepened access of our military contract”, said Morten Henneveld, CEO of OssDsign.
The Veterans Health Administration (VHA) is the largest integrated healthcare system in the US with nearly 1,300 healthcare facilities serving 9 million veterans across the nation. Having access nationwide represents a significant commercial step forward for OssDsign.
OssDsign Catalyst is a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. The graft is composed of a proprietary nanocrystalline structure which is resorbed and replaced by new and healthy bone tissue in the body. 12-month results from the clinical study TOP FUSION, published in the peer-reviewed journal Biomedical Journal of Scientific & Technical Research, show a 93 % spinal fusion rate as well as improvements in quality of life and pain following surgery with OssDsign Catalyst.
Red One is a government-certified Service-Disabled Veteran Owned Small Business (SDVOSB) and Disability-Owned Business Enterprise (DOBE) that connects leading medical and pharmaceutical manufacturers to US Department of Veterans Affairs (VA) and Department of Defense (DoD) hospitals.
For further information, please contact:
Morten Henneveld, CEO, OssDsign AB
Tel: +46 73 382 43 90, email: morten.henneveld@ossdsign.com
Certified Adviser
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)
About OssDsign
OssDsign is a developer and global provider of next generation orthobiologics products. Based on cutting edge material science, the company develops and markets products that support the body's own healing capabilities, giving patients back the life they deserve. The company has a strong presence in the U.S. market. OssDsign's share is traded on Nasdaq First North Growth Market in Stockholm, Sweden.
Tags: